Are Energy Stocks Flashing a Buy Signal?

Oil-and-gas stocks once again reached selling climaxes last week

by Alex Eppstein

Published on Aug 10, 2015 at 1:45 PM
Updated on Aug 10, 2015 at 1:56 PM

Last week, Schaeffer's Quantitative Analyst Chris Prybal took a look at selling climaxes. These weekly signals occur when a 52-week low is hit during a week, but the stock actually ends the week above its prior week's close. Prybal noted that selling climaxes can sometimes present contrarian buying signals.

Having said that, below is a list of stocks and other equities that reached selling climaxes last week. As you can see, the energy sector was once again well-represented -- among which was Transocean LTD (NYSE:RIG), a recent favorite among option traders. (Of course, extreme selling among oil-and-gas names is hardly surprising, given crude's prolonged sell-off.) In any case, RIG hit an intraweek (and 20-year) low of $12.07 on Wednesday, before closing the week at $13.57 -- above the prior Friday's settlement price of $13.26. Today, the shares are up 5.6% at $14.33, after Jefferies upped its outlook to "hold" from "underperform" and its price target to $13 from $12.

150810sellingclimaxes

Also reaching selling climaxes were a number of CBOE Volatility Index (VIX) products. As Schaeffer's contributor Adam Warner touched upon earlier, the iPath S&P 500 VIX Short-Term Futures ETN (VXX) panned a record low on Wednesday, but took a sharp bounce to end on a weekly gain. Other VIX products on the selling climax list were the ProShares Trust Ultra VIX Short-Term Futures ETF (NYSEARCA:UVXY) and the ProShares Trust II (NYSEARCA:VIXY).

A Schaeffer's exclusive!

The Expert's Guide

Access your FREE trading earning announcements before it's too late!


 
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The Latest Investor's Guide to Precious Metals
Learn how to protect savings and maximize returns by investing in precious metals.
Patent Lawsuit Loss Sends AMRN Stock Spiraling
Amarin just lost a major U.S. patent lawsuit for its heart drug Vascepa
RH Stock Sinks Despite Earnings Beat
J.P. Morgan Securities and Cowen and Company cut their price targets
The Latest Investor's Guide to Precious Metals
Learn how to protect savings and maximize returns by investing in precious metals.